Effectiveness of COVID-19 treatment with nirmatrelvir-ritonavir or molnupiravir among U.S. Veterans: target trial emulation studies with one-month and six-month outcomes

Kristina L. Bajema, Kristin Berry, Elani Streja, Nallakkandi Rajeevan, Yuli Li, Lei Yan, Francesca Cunningham, Denise M. Hynes, Mazhgan Rowneki, Amy Bohnert, Edward J. Boyko, Theodore J. Iwashyna, Matthew L. Maciejewski, Thomas F. Osborne, Elizabeth M. Viglianti, Mihaela Aslan, Grant D. Huang, George N. Ioannou
doi: https://doi.org/10.1101/2022.12.05.22283134

Data Availability

All data produced in the present work are contained in the manuscript.

Back to top
Posted December 16, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Effectiveness of COVID-19 treatment with nirmatrelvir-ritonavir or molnupiravir among U.S. Veterans: target trial emulation studies with one-month and six-month outcomes
Kristina L. Bajema, Kristin Berry, Elani Streja, Nallakkandi Rajeevan, Yuli Li, Lei Yan, Francesca Cunningham, Denise M. Hynes, Mazhgan Rowneki, Amy Bohnert, Edward J. Boyko, Theodore J. Iwashyna, Matthew L. Maciejewski, Thomas F. Osborne, Elizabeth M. Viglianti, Mihaela Aslan, Grant D. Huang, George N. Ioannou
medRxiv 2022.12.05.22283134; doi: https://doi.org/10.1101/2022.12.05.22283134
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area